| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29,344 |
25,801 |
$2.20M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,113 |
7,520 |
$933K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,333 |
5,835 |
$735K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,980 |
5,540 |
$677K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
16,144 |
15,000 |
$651K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,767 |
3,575 |
$462K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,006 |
3,723 |
$450K |
| 96127 |
|
17,961 |
15,610 |
$342K |
| 99177 |
|
11,369 |
10,722 |
$200K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
7,810 |
6,716 |
$156K |
| 96160 |
|
6,601 |
6,148 |
$136K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,637 |
3,527 |
$89K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,992 |
1,801 |
$88K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,057 |
2,804 |
$88K |
| 96161 |
|
4,035 |
3,864 |
$80K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
471 |
447 |
$59K |
| 87631 |
|
478 |
394 |
$46K |
| 36416 |
|
15,298 |
14,146 |
$46K |
| 92558 |
|
2,173 |
1,956 |
$45K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,613 |
2,050 |
$44K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
805 |
763 |
$37K |
| 92551 |
|
6,400 |
5,916 |
$36K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
537 |
459 |
$35K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,812 |
2,513 |
$27K |
| 99188 |
|
870 |
803 |
$18K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
143 |
141 |
$18K |
| D0145 |
Oral evaluation for a patient under three years of age |
701 |
626 |
$15K |
| 83655 |
|
1,347 |
1,292 |
$14K |
| 99383 |
|
99 |
94 |
$13K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
682 |
668 |
$13K |
| 99384 |
|
64 |
61 |
$10K |
| 99442 |
|
177 |
163 |
$7K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
69 |
68 |
$6K |
| 87420 |
|
584 |
551 |
$6K |
| 99051 |
|
661 |
614 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
355 |
316 |
$4K |
| 92587 |
|
114 |
111 |
$4K |
| 0071A |
|
115 |
99 |
$4K |
| 80061 |
Lipid panel |
323 |
300 |
$4K |
| D1206 |
Topical application of fluoride varnish |
175 |
154 |
$3K |
| 94760 |
|
2,232 |
1,881 |
$3K |
| 0072A |
|
78 |
75 |
$3K |
| 99215 |
Prolong outpt/office vis |
15 |
15 |
$3K |
| 99382 |
|
16 |
16 |
$2K |
| 99381 |
|
12 |
12 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
174 |
156 |
$1K |
| 90473 |
|
41 |
41 |
$995.99 |
| 92567 |
|
67 |
63 |
$902.12 |
| 92552 |
|
53 |
53 |
$664.56 |
| 99174 |
|
173 |
44 |
$600.00 |
| 99173 |
|
99 |
85 |
$592.80 |
| 81000 |
|
195 |
177 |
$524.32 |
| 81001 |
|
137 |
133 |
$374.48 |
| 82947 |
|
96 |
94 |
$311.25 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
16 |
16 |
$310.80 |
| 94010 |
|
12 |
12 |
$259.08 |
| 85018 |
|
13,248 |
12,307 |
$157.85 |
| 81025 |
|
20 |
19 |
$114.76 |
| 86580 |
|
16 |
14 |
$100.16 |
| 90686 |
|
6,031 |
5,716 |
$38.73 |
| 90674 |
|
2,120 |
2,030 |
$32.29 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
135 |
115 |
$29.43 |
| J7510 |
Prednisolone oral, per 5 mg |
15 |
14 |
$28.06 |
| 90671 |
|
594 |
581 |
$0.09 |
| 90651 |
|
1,201 |
1,153 |
$0.05 |
| 90621 |
|
89 |
83 |
$0.02 |
| 90670 |
|
2,401 |
2,265 |
$0.01 |
| 91307 |
|
243 |
223 |
$0.00 |
| 90680 |
|
980 |
951 |
$0.00 |
| 90723 |
|
527 |
511 |
$0.00 |
| 90697 |
|
514 |
496 |
$0.00 |
| 90619 |
|
278 |
263 |
$0.00 |
| 90620 |
|
175 |
163 |
$0.00 |
| 90696 |
|
66 |
64 |
$0.00 |
| A7015 |
Aerosol mask, used with dme nebulizer |
17 |
12 |
$0.00 |
| 90698 |
|
17 |
17 |
$0.00 |
| 90734 |
|
480 |
466 |
$0.00 |
| 90461 |
|
1,831 |
1,699 |
$0.00 |
| 90685 |
|
408 |
347 |
$0.00 |
| 90648 |
|
1,284 |
1,216 |
$0.00 |
| 90710 |
|
500 |
467 |
$0.00 |
| 90715 |
|
214 |
210 |
$0.00 |
| 90633 |
|
932 |
871 |
$0.00 |
| 90661 |
|
580 |
572 |
$0.00 |
| 81003 |
|
55 |
47 |
$0.00 |
| 90700 |
|
66 |
66 |
$0.00 |
| 90681 |
|
25 |
24 |
$0.00 |
| 90672 |
|
45 |
45 |
$0.00 |
| 91300 |
|
13 |
12 |
$0.00 |